Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

  • Filters activated: Cancer. Clear all to show 31 items.
1.

Nucleotide-binding oligomerization domain 1 acts in concert with the cholecystokinin receptor agonist, cerulein, to induce IL-33-dependent chronic pancreatitis.

Watanabe T, Sadakane Y, Yagama N, Sakurai T, Ezoe H, Kudo M, Chiba T, Strober W.

Mucosal Immunol. 2016 Sep;9(5):1234-49. doi: 10.1038/mi.2015.144. Epub 2016 Jan 27.

PMID:
26813347
2.

A TNF-α-CCL20-CCR6 axis regulates Nod1-induced B cell responses.

Paradis M, Mindt BC, Duerr CU, Rojas OL, Ng D, Boulianne B, McCarthy DD, Yu MD, Summers deLuca LE, Ward LA, Waldron JB, Philpott DJ, Gommerman JL, Fritz JH.

J Immunol. 2014 Mar 15;192(6):2787-99. doi: 10.4049/jimmunol.1203310. Epub 2014 Feb 17.

3.

Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis.

Tsuji Y, Watanabe T, Kudo M, Arai H, Strober W, Chiba T.

Immunity. 2012 Aug 24;37(2):326-38. doi: 10.1016/j.immuni.2012.05.024. Epub 2012 Aug 16.

4.

Analgesic effects of chemically synthesized NOD1 and NOD2 agonists in mice.

Sato T, Shikama Y, Shimauchi H, Endo Y, Takada H.

Innate Immun. 2011 Feb;17(1):54-9. doi: 10.1177/1753425909351904. Epub 2010 Jan 18.

PMID:
20083500
5.

Enhanced induction of a histamine-forming enzyme, histidine decarboxylase, in mice primed with NOD1 or NOD2 ligand in response to various Toll-like receptor agonists.

Funayama H, Huang L, Asada Y, Endo Y, Takada H.

Innate Immun. 2010 Aug;16(4):265-72. doi: 10.1177/1753425909341070. Epub 2009 Aug 26.

PMID:
19710098
6.

Nod1 and Nod2 induce CCL5/RANTES through the NF-kappaB pathway.

Werts C, le Bourhis L, Liu J, Magalhaes JG, Carneiro LA, Fritz JH, Stockinger S, Balloy V, Chignard M, Decker T, Philpott DJ, Ma X, Girardin SE.

Eur J Immunol. 2007 Sep;37(9):2499-508.

8.

New convenient synthesis of immunostimulating peptides containing meso-diaminopimelic acid. Syntheses of FK-565 and FK-156.

Kolodziejczyk AM, Kolodziejczyk AS, Stoev S.

Int J Pept Protein Res. 1992 Apr;39(4):382-7.

PMID:
1428528
9.

Stimulatory effects of FK156 in a panel of tests designed to detect changes in immune function.

Weston BJ, Henderson DC, Seal S, Spackman V, Robertson F, Dewdney JM.

Int J Immunopharmacol. 1991;13(2-3):117-24.

PMID:
2071288
10.

[Low-molecular weight immunomodulators of microbial origin].

Khurnova LM, Ivanitskaia LP.

Antibiot Khimioter. 1989 Oct;34(10):786-92. Review. Russian. No abstract available.

PMID:
2694992
12.

Effect of anticancer drugs on the release of interferon gamma in vitro.

Ahmed K, van der Meide PH, Turk JL.

Cancer Immunol Immunother. 1989;30(4):213-8.

PMID:
2480848
14.

Immunoactive peptides, FK 156 and FK 565. IV. Activation of mouse macrophages.

Watanabe Y, Tawara S, Mine Y, Kikuchi H.

J Antibiot (Tokyo). 1985 Dec;38(12):1781-7.

15.

Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes.

Weissmann N, Leyhausen G, Maidhof A, Tanaka W, Umezawa H, Müller WE.

J Antibiot (Tokyo). 1985 Jun;38(6):772-8.

16.

Low-molecular-weight immunomodifiers produced by micro-organisms.

Umezawa H.

Biotechnol Genet Eng Rev. 1985;3:255-73. Review. No abstract available.

PMID:
2936359
17.

Studies on structure-activity relationships of FK-156, an immunostimulating peptide, and related compounds. II. Synthesis of N2-(gamma-D-glutamyl)-2(L), 2'(D)-diaminopimelic acid as the minimal essential structure of FK-156.

Takeno H, Okada S, Yonishi S, Hemmi K, Nakaguchi O, Kitaura Y, Hashimoto M.

Chem Pharm Bull (Tokyo). 1984 Aug;32(8):2932-41. No abstract available.

PMID:
6518579
18.

Studies on structure-activity relationships of FK-156, an immunostimulating peptide, and related compounds. I. Synthesis of stereoisomeric analogues of FK-156.

Takeno H, Okada S, Hemmi K, Aratani M, Kitaura Y, Hashimoto M.

Chem Pharm Bull (Tokyo). 1984 Aug;32(8):2925-31. No abstract available.

PMID:
6518578
19.

Immunoactive peptides, FK-156 and FK-565. III. Enhancement of host defense mechanisms against infection.

Mine Y, Watanabe Y, Tawara S, Yokota Y, Nishida M, Goto S, Kuwahara S.

J Antibiot (Tokyo). 1983 Aug;36(8):1059-66.

20.

Immunoactive peptides, FK-156 and FK-565. II. Restoration of host resistance to microbial infection in immunosuppressed mice.

Yokota Y, Mine Y, Wakai Y, Watanabe Y, Nishida M, Goto S, Kuwahara S.

J Antibiot (Tokyo). 1983 Aug;36(8):1051-8.

Supplemental Content

Loading ...
Support Center